2021-01-11,Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
2021-01-04,Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-04,Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
2020-12-16,Passage Bio Announces Gene Therapy Manufacturing Research and Development Site
2020-12-15,Is PASG A Good Stock To Buy Now?
2020-12-11,"The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street"
2020-12-10,Passage Bio Receives MHRA Clinical Trial Authorization for PBGM01 for Treatment of GM1 Gangliosidosis
2020-12-07,Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
2020-11-24,Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans
2020-11-23,Passage Bio to Present at Piper Sandler 32nd Annual Healthcare Conference
2020-11-11,Passage Bio Highlights University of Pennsylvanias Gene Therapy Programs Newly Published Research to Prevent Toxicity Associated with Gene Therapy
2020-11-11,Passage Bio to Participate in Upcoming November Investor Conferences
2020-11-10,Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
2020-11-09,Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1
2020-11-04,"Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020"
2020-10-28,Passage Bios PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
2020-10-26,Passage Bios PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis
2020-10-14,Passage Bio (PASG) Looks Good: Stock Adds 5.4% in Session
2020-10-13,"Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal Fluid Corrects Neurological Disease, Supporting Advancement of PBGM01 into Clinic"
2020-10-06,Passage Bio to Participate in 2020 Virtual Cell & Gene Meeting on the Mesa
2020-09-25,Passage Bio to Participate in Upcoming OctoberÂ Investor Conferences
2020-09-17,Passage Bio Announces Publication of Preclinical Gene Therapy Study Data from Frontotemporal Dementia Program
2020-09-03,Passage Bio to Participate in Citis 15th Annual BioPharma Virtual Conference
2020-08-26,"Have Insiders Been Buying Passage Bio, Inc. (NASDAQ:PASG) Shares This Year?"
2020-08-13,Passage Bio Reports Second Quarter 2020 Financial Results and Recent Business Highlights
2020-08-07,"Passage Bio to Report Second Quarter 2020 Financial Results on August 13, 2020"
2020-06-26,Passage Bio Added to Russell 2000 Index
2020-06-04,Zacks.com featured highlights include: Aeglea BioTherapeutics and Passage Bio
2020-06-04,Passage Bio to Present at Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-28,Companies Like Passage Bio (NASDAQ:PASG) Are In A Position To Invest In Growth
2020-05-21,Passage Bio Receives Rare Pediatric Disease Designation for PBGM01 for Patients with GM1 Gangliosidosis
2020-05-12,Passage Bio Announces Presentation of Data from Animal Models of Krabbe Disease at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting
2020-05-11,Passage Bio Reports First Quarter 2020 Financial Results and Recent Business Highlights
2020-05-07,Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania
2020-05-04,"Passage Bio to Report First Quarter 2020 Financial Results on May 11, 2020"
2020-04-21,FDA Grants Passage Bio Orphan Drug Designation for PBGM01 for Treatment of Infantile GM1 Gangliosidosis
2020-04-08,Passage Bio to Present at 19th Annual Needham Healthcare Conference
2020-03-27,Passage Bio to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
2020-03-09,Passage Bio Announces Exercise of Underwriters Option to Purchase Additional Shares
2020-03-05,Passage Bio Appoints Athena Countouriotis to Board of Directors
2020-02-27,Passage Bio Announces Pricing of Initial Public Offering
